Journal of Surgery Concepts & Practice ›› 2018, Vol. 23 ›› Issue (03): 258-262.doi: 10.16139/j.1007-9610.2018.03.015
• Original article • Previous Articles Next Articles
FENG Runhuaa,b,c, SAH K. Birendraa, LU Shenga, YUAN Feid, XU Haimind, LIU Bingyab,c, YAN Mina, LI Chena,b,c, ZHU Zhengganga,b,c
Received:
2018-02-28
Published:
2020-07-25
CLC Number:
FENG Runhua, SAH K. Birendra, LU Sheng, YUAN Fei, XU Haimin, LIU Bingya, YAN Min, LI Chen, ZHU Zhenggang. Clinical significance of Crk expression in gastric cancer[J]. Journal of Surgery Concepts & Practice, 2018, 23(03): 258-262.
[1] Ferlay J, Soerjomataram I, Dikshit R, et al.Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012[J]. Int J Cancer, 2015,136(5):E359-E386. [2] Chen W, Zheng R, Zhang S, et al.Cancer incidence and mortality in China in 2013: an analysis based on urba-nization level[J]. Chin J Cancer Res,2017,29(1):1-10. [3] Chang SC, Liu KH, Hung CY, et al.Adjuvant chemothe-rapy improves survival in stage Ⅲ gastric cancer after D2 surgery[J]. J Cancer,2018,9(1):81-91. [4] Kusano T, Shiraishi N, Shiroshita H, et al.Poor prognosis of advanced gastric cancer with metastatic suprapancrea-tic lymph nodes[J]. Ann Surg Oncol,2013,20(7):2290-2295. [5] Guggenheim DE, Shah MA.Gastric cancer epidemiology and risk factors[J]. J Surg Oncol,2013,107(3):230-236. [6] Kumar S, Fajardo JE, Birge RB, et al.Crk at the quarter century mark: perspectives in signaling and cancer[J]. J Cell Biochem,2014,115(5):819-825. [7] Fioretos T, Heisterkamp N, Groffen J, et al.CRK proto-oncogene maps to human chromosome band 17p13[J]. Oncogene,1993,8(10):2853-2855. [8] Matsuda M, Tanaka S, Nagata S, et al.Two species of human CRK cDNA encode proteins with distinct biological activities[J]. Mol Cell Biol,1992,12(8):3482-3489. [9] Feller SM.Crk family adaptors-signalling complex formation and biological roles[J]. Oncogene,2001,20(44):6348-6371. [10] Ren R, Ye ZS, Baltimore D.Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites[J]. Genes Dev,1994,8(7):783-795. [11] Kar B, Reichman CT, Singh S, et al.Proapoptotic function of the nuclear Crk Ⅱ adaptor protein[J]. Biochemistry,2007,46(38):10828-10840. [12] Tsuda M, Tanaka S.Roles for crk in cancer metastasis and invasion[J]. Genes Cancer,2012,3(5-6):334-340. [13] Nishihara H, Tanaka S, Tsuda M, et al.Molecular and immunohistochemical analysis of signaling adaptor protein Crk in human cancers[J]. Cancer Lett,2002,180(1):55-61. [14] Kumar S, Davra V, E Obr A, et al. Crk adaptor protein promotes PD-L1 expression, EMT and immune evasion in a murine model of triple-negative breast cancer[J]. Oncoimmunology,2017,7(1):e1376155. [15] Matsumoto R, Tsuda M, Wang L, et al.Adaptor protein CRK induces epithelial-mesenchymal transition and metastasis of bladder cancer cells through HGF/c-Met feedback loop[J]. Cancer Sci,2015,106(6):709-717. [16] Yamada S, Yanamoto S, Kawasaki G, et al.Overexpression of CRKⅡ increases migration and invasive potential in oral squamous cell carcinoma[J]. Cancer Lett,2011,303(2):84-91. [17] Rodrigues SP, Fathers KE, Chan G, et al.CrkⅠ and CrkⅡ function as key signaling integrators for migration and invasion of cancer cells[J]. Mol Cancer Res,2005,3(4):183-194. [18] Linghu H, Tsuda M, Makino Y, et al.Involvement of adaptor protein Crk in malignant feature of human ovarian cancer cell line MCAS[J]. Oncogene,2006,25(25):3547-3556. [19] Dhupkar P, Zhao H, Mujoo K, et al.Crk Ⅱ silencing down-regulates IGF-IR and inhibits migration and invasion of prostate cancer cells[J]. Biochem Biophys Rep,2016,8:382-388. [20] Elmansuri AZ, Tanino MA, Mahabir R, et al.Novel signaling collaboration between TGF-β and adaptor protein Crk facilitates EMT in human lung cancer[J]. Oncotarget,2016,7(19):27094-27107. [21] Suzuki M, Mimuro H, Suzuki T, et al.Interaction of CagA with Crk plays an important role in Helicobacter pylori-induced loss of gastric epithelial cell adhesion[J]. J Exp Med,2005,202(9):1235-1247. [22] Feng R, Chen X, Yu Y, et al.miR-126 functions as a tumour suppressor in human gastric cancer[J]. Cancer Lett,2010,298(1):50-63. |
[1] | YIN Yanjiang, LUO Zhiwen, CHEN Xiao, ZHANG Yefan, HUANG Zhen, ZHAO Hong, ZHAO Jianjun, LI Zhiyu, ZHOU Jianguo, CAI Jianqiang, BI Xinyu. Relationship between surgical margin and prognosis of patients with intrahepatic cholangiocarcinoma [J]. Journal of Surgery Concepts & Practice, 2022, 27(3): 221-228. |
[2] | YANG Cuiyan, WANG Haoyu, CHEN Xiaosong, SHEN Kunwei. Study on tumour suppressor gene TP53 mutation and prognosis in patients with triple-negative breast cancer [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 421-428. |
[3] | DAI Zhiqiang, ZHENG Jinxin, TANG Zhaoqing, ZHANG Qi, GU Yuan, SHI Zhongyi, HU Guohua, SUN Yihong. Metastatic lymph node ratio to evaluate prognosis of patients with stage Ⅱ-Ⅲ gastric cancer after radical gastrectomy [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 429-434. |
[4] | LI Nana, QI Tao, ZHU Liming. Clinical value of serum pepsinogen,gastrin 17 and Helicobacter pylori IgG antibody in primary screening of gastric diseases [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(04): 509-513. |
[5] | NIE Mingming, ZHU Zhenggang. Clinical significance of diagnostic laparoscopy on precision staging in advanced gastric cancer [J]. Journal of Surgery Concepts & Practice, 2022, 27(04): 365-370. |
[6] | GUO Liangqi, YAN Zhilong, ZHANG Moucheng. Laparoscopic intragastric surgery in treating of gastric submucosal tumor and early gastric cancer [J]. Journal of Surgery Concepts & Practice, 2022, 27(04): 380-383. |
[7] | ZHAO Liqin, GUO Weijian, YU Nuoya, WU Junwei, ZHANG Jun. Effects of activin A on migration and aerobic glycolysis of gastric cancer cells [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(04): 317-323. |
[8] | CHEN Min, CHE Zaiqian, CHEN Ying, MA Li, ZHAO Bing, ZHOU Weijun, MAO Enqiang, CHEN Erzhen. Clinical study of leukocyte-to-platelet ratio in early evaluating prognosis of sepsis [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(03): 208-213. |
[9] | LI Lei, YUAN Fei, WANG Chaofu, XU Haimin, WANG Ting. Ampullary adenocarcinoma: analysis of the clinicopathological features and prognostic factors [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(03): 355-361. |
[10] | YANG Chunxue, XU Haimin, DA Qian. Clinicopathological features of pancreatic intraductal oncocytic papillary neoplasm: a report of 5 cases [J]. Journal of Surgery Concepts & Practice, 2022, 27(01): 52-57. |
[11] | MU Yang, CHEN Xin. Prognotic significance of plasma procalcitonin and C⁃reactive protein in evaluation of multiple trauma patients [J]. Journal of Surgery Concepts & Practice, 2021, 26(6): 532-536. |
[12] | LU Weihui, LIU Wei, WANG Cong, WANG Zhenglin. Effects of CXCR2 on invasion, migration and apoptosis of gastric cancer cells [J]. Journal of Surgery Concepts & Practice, 2021, 26(5): 430-436. |
[13] | FENG Guowei, ZHANG Xiaojuan, GUO Rui, GUAN Zhe, WANG Yue. The prognostic value of pretreatment 18F-FDG PET/CT in extranodal natural killer/T-cell lymphoma [J]. Journal of Diagnostics Concepts & Practice, 2021, 20(06): 533-539. |
[14] | WANG Zhaohui, WU Haibo. Clinicopathological analysis of 31 cases of gastric schwannoma [J]. Journal of Diagnostics Concepts & Practice, 2021, 20(06): 552-556. |
[15] | LIANG Yali, ZHAO Haigang, XIANG Guangyu. The stress-induced hyperglycemia ratio in the prognosis prediction of patients with acute ischemic stroke one year after thrombolytic therapy [J]. Journal of Diagnostics Concepts & Practice, 2021, 20(06): 562-566. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||